Testing version — LOERadar is in active testing. Features and data may change.
ZEMPLAR (PARICALCITOL) | LOERadar
ZEMPLAR
NDA
PARICALCITOL | N021606 | ABBVIE INC
3 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (3)
Sort:
#001 — 1MCG
RLD
0 patents0 exclusivities▴
CAPSULE;ORAL | Approved: May 26, 2005
No patent or exclusivity listings for this strength.
#002 — 2MCG
RLD
0 patents0 exclusivities▾
CAPSULE;ORAL | Approved: May 26, 2005
#003 — 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**